STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

PDSB PDS BIOTECHNOLOGY CORPORATION StockScouter® Report

2

StockScouter® Score

PDS BIOTECHNOLOGY CORPORATION, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • The 50-day moving average for PDSB is significantly below its 200-day moving average. Negative
  • Short-term relative price momentum exhibits meaningful weakness. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

F
N/A
N/A
F

Previous Ratings